2,715 recalls tagged with “immediate action”.
Radnostix, Inc. is recalling 16 units of SODIUM IODIDE I-131 Solution distributed nationwide in the United States and Puerto Rico. The product contains particulate matter due to production issues. Healthcare providers and patients should stop using the product immediately and await a recall notification by letter.
Asteria Health recalled 24,099 Estradiol, 10 mg pellets on January 26, 2026, due to potential metal particulate contamination. Consumers should stop using the product immediately. The recall affects pellets distributed nationwide in the USA.
Beacon Promotions recalled 541 units of repackaged M&Ms Peanut candies on January 26, 2026. The candies contain undeclared allergens including milk, soy, and peanuts. Consumers should stop using the product immediately and seek a refund or replacement.
Granules Pharmaceuticals Inc. recalled 71,424 bottles of Trazodone Hydrochloride on January 26, 2026. The recall stems from the presence of foreign tablets or capsules in the product. Consumers should stop using the medication immediately and consult their healthcare provider.
Philips Medical Systems recalled 326 Azurion 5 M12 systems on January 26, 2026. The table may move unexpectedly when the Reset Geometry button is pressed, posing a risk to patients and healthcare providers. Immediate cessation of use is advised.
Philips Medical Systems recalled 1,503 Azurion 7 B20 systems on January 26, 2026. The devices may move unexpectedly when the Reset Geometry button is pressed, posing a risk of injury. Healthcare providers must stop using the device and follow recall instructions immediately.
Philips Medical Systems Nederland B.V. recalled 922 Azurion 5 M20 systems on January 26, 2026, due to a defect that causes unexpected table movement. This hazard can occur even with an active table lock when the Reset Geometry button is pressed. The recall includes 101 units in the U.S. and 821 units distributed worldwide.
Philips Medical Systems recalled 1,979 Azurion 7 M12 Systems on January 26, 2026. The table may move unexpectedly when the Reset Geometry button is pressed, posing a high risk of injury. Healthcare providers and patients should stop using the devices immediately.
Asteria Health recalled 50,990 Estradiol pellets on January 26, 2026, due to potential metal particulate matter contamination. The recall affects products distributed nationwide in the USA. Consumers should stop using the pellets immediately and seek guidance from healthcare providers.
Asteria Health recalled 1,699 sterile estradiol pellets on January 26, 2026, due to potential metal particulate contamination. Consumers should stop using the product immediately and contact their healthcare provider for advice. The recall affects pellets distributed nationwide in the USA.
Asteria Health recalled 1,631 sterile pellets of Testosterone and Triamcinolone Acetonide on January 26, 2026, due to potential metal contamination. Consumers should stop using the product immediately. This recall affects products distributed nationwide in the USA.
Asteria Health recalled 146 testosterone pellets on January 26, 2026, due to potential metal particulate matter. The recall affects products distributed nationwide in the USA. Consumers and healthcare providers must stop using the product immediately.
Asteria Health recalled 14,848 estradiol pellets on January 26, 2026, due to potential metal particulate contamination. Consumers and healthcare providers must stop using the product immediately. The recall is classified as Class II, indicating a high hazard level.
Asteria Health recalled 4,599 testosterone pellets on January 26, 2026. The recall follows concerns over potential metal particulate matter contamination. Consumers should stop using the product immediately and seek guidance from healthcare providers.
Asteria Health recalled 715 units of Estradiol, 37.5 mg pellets on January 26, 2026. The recall follows the potential presence of metal particulate matter in the product. Consumers should stop using the pellets immediately and contact their healthcare provider for further guidance.
Asteria Health recalled 1,475 estradiol pellets on January 26, 2026, due to potential metal particulate contamination. This recall affects products distributed nationwide in the United States. Consumers should stop using the product immediately and seek guidance from their healthcare provider.
Asteria Health recalled 62,581 testosterone pellets on January 26, 2026, due to potential metal particulate contamination. Consumers should stop using the product immediately and contact their healthcare provider for guidance. The recall affects testosterone pellets with specific lot numbers and expiration dates.
Asteria Health recalled 153,498 testosterone pellets on January 26, 2026, due to potential metal particulate contamination. The recall affects lots expiring between June and September 2026. Consumers and healthcare providers must stop using the product immediately.
Asteria Health recalled 194,336 testosterone pellets on January 26, 2026 due to potential metal contamination. Consumers must stop using the product immediately and contact their healthcare providers. The recall affects nationwide distribution in the USA.
Asteria Health recalled 2,442 units of Estradiol, 25 mg pellets on January 26, 2026. The recall follows the discovery of potential metal particulate matter in the product. Consumers must stop using the pellets immediately and consult their healthcare providers for guidance.